Living prediction method related to glioma epithelial mesenchymal transition
The invention discloses a survival prediction method related to glioma epithelial mesenchymal transition, and relates to the field of bioinformatics. According to the invention, biomarkers of epithelial mesenchymal transition (EMT) are utilized to assess their influence on the prognosis of glioma pa...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a survival prediction method related to glioma epithelial mesenchymal transition, and relates to the field of bioinformatics. According to the invention, biomarkers of epithelial mesenchymal transition (EMT) are utilized to assess their influence on the prognosis of glioma patients, and in order to ensure the accuracy and generalization ability of the model, a plurality of independent data sets are adopted for verification. These datasets include patient samples of different geographic locations, races and treatment contexts, enabling a wide range of verification of the effectiveness and application of the model. The method comprehensively utilizes data of a plurality of public databases, including a gene comprehensive expression database, a cancer genome map database and a Chinese glioma genome map. The integration analysis of the multi-source data enhances the comprehensiveness of the model and the representativeness of the data, so that the prediction result is more accurate and rel |
---|